Twelve Month Follow-Up Evaluation of Subjects Participating in DUSA-CP0108 (A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities)
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2016
Price : $35 *
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors DUSA Pharmaceuticals
- 22 Sep 2016 Status changed from active, no longer recruiting to completed.
- 14 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Aug 2014 New trial record